Medicine for treating children with congestive splenomegaly
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for congestive and splenomegaly, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of liver cell damage, no benefit of surgical treatment, mild adverse reactions, etc., to relieve portal hypertension, unique formula , delay the effect of splenomegaly
Inactive Publication Date: 2014-05-21
武英
View PDF4 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, the above-mentioned surgical treatment has the following disadvantages: ①The operation requires children to be over 6 years old; ②For the cases of liver cirrhosis, the liver cells have been seriously damaged, and the surgical treatment is not beneficial
Therefore, there is still a lack of a drug that is specially used for children and has mild adverse reactions for the treatment of congestive splenomegaly.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0028] Example 1, the weight ratio of raw materials: 6g of chamomile, 8g of bellflower, 8g of cat's claw, 6g of weeping grass, 6g of pangolin, 8g of red bean, 6g of anemarrhena, 8g of citrus aurantium, and 3g of dried ginger.
Embodiment 2
[0029] Example 2, the weight ratio of raw materials: 10g of C. chinensis, 15g of bellflower, 15g of cat's claw, 10g of weeping grass, 10g of pangolin, 15g of red bean, 10g of anemarrhena, 15g of citrus aurantium, and 6g of dried ginger.
Embodiment 3
[0030] Example 3, the weight ratio of the raw materials: 8g of the yellow grass, 10g of the bellflower, 10g of the cat's claw, 8g of the weeping grass, 8g of the pangolin, 10g of the red bean, 8g of Anemarrhena, 10g of Citrus aurantium, and 5g of dried ginger.
[0031] When in use, add water to decoct the traditional Chinese medicines of the present invention, chrysanthemum chinensis, bell grass, cat's claw grass, weeping grass, pangolin, red bean, anemarrhena, dried ginger and citrus aurantium, combine the filtrates, and take it in the morning and evening. The dosage of the above-mentioned drugs is a single daily dose. Children over 10 years old take the full dose, 5-10 years old take half the dose, and 1-5 years old take 1 / 4 of the dose.
[0032] The effective combination and coordination of the above drugs can effectively achieve the purpose of treating congestive splenomegaly in children, and has less side effects. The above results are fully proved by the clinical data, a...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicine for treating children with congestive splenomegaly, and aims to solve the problem of the treating the children with the congestive splenomegaly. The medicine is characterized by being prepared by adopting multiple plurality of traditional Chinese medicines, and the formula of the raw materials and the weight proportion are as follows: 6 to 10 parts of penthorum chinense pursh, 8 to 15 parts of rust-coloured crotalaria herb with root, 8 to 15 parts of ternate buttercup roots, 6 to 10 parts of sedum sarmentosum, 6 to 10 parts of manis pentadactyla, 8 to 15 parts of phaseolus calcaratus, 6 to 10 parts of rhizoma anemarrhenae, 8 to 15 parts of immature bitter oranges and 3 to 6 parts of rhizoma zingiberis. The clinical experiment proves that the medicine has the characteristics of good treatment effect and higher safety during the treatment of the children with the congestive splenomegaly. Therefore, the medicine is worthy of clinical applications and popularization.
Description
technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating congestive splenomegaly in children. Background technique [0002] Chronic congestive splenomegaly (chronic congestive splenomegaly), also known as portal hypertension, is a congestive chronic progressive disease of unknown cause, clinically characterized by chronic progressive splenomegaly, progressive anemia, white blood cells and platelets Reduction and gastrointestinal bleeding are the main manifestations, and signs such as ascites, jaundice, liver dysfunction, and cirrhosis appear in the late stage. [0003] Chronic congestive splenomegaly is often caused by portal vein obstruction for various reasons. The splenic vein belongs to the portal vein system, and 70% of the splenic vein blood flows into the portal vein in normal people. Congestive splenomegaly can occur if the portal vein is obstructed and blood return to the spleen is impaired...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more